The Pfizer-BioNTech vaccine, authorized by the U.S. Food and Drug Administration in late October last year, is the only vaccine available for children aged five to 11 years in the United States. The CDC has not changed the booster interval recommendation for people who have received the Johnson & Johnson or the Moderna  vaccine, which remains at two and six months respectively. A CDC advisory panel is set to meet on Wednesday to discuss the use of a booster dose of Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15 years. So you know which stock to buy $Moderna, Inc.(MRNA)$$Pfizer(PFE)$